Comparison of Methicillin-Resistant Staphylococcus aureus Isolates from Cellulitis and from Osteomyelitis in a Taiwan Hospital, 2016–2018

Methicillin-resistant Staphylococcus aureus (MRSA) causes superficial infections such as cellulitis or invasive infections such as osteomyelitis; however, differences in MRSA isolates from cellulitis (CL-MRSA) and from osteomyelitis (OM-MRSA) at the same local area remain largely unknown. A total of 221 MRSA isolates including 106 CL-MRSA strains and 115 OM-MRSA strains were collected at Chang-Gung Memorial Hospital in Taiwan between 2016 and 2018, and their genotypic and phenotypic characteristics were compared. We found that OM-MRSA isolates significantly exhibited higher rates of resistance to multiple antibiotics than CL-MRSA isolates. Genotypically, OM-MRSA isolates had higher proportions of the SCCmec type III, the sequence type ST239, and the spa type t037 than CL-MRSA isolates. Besides the multidrug-resistant lineage ST239-t037-SCCmecIII more prevalent in OM-MRSA, higher antibiotic resistance rates were also observed in several other prevalent lineages in OM-MRSA as compared to the same lineages in CL-MRSA. Furthermore, when prosthetic joint infection (PJI) associated and non-PJI-associated MRSA strains in osteomyelitis were compared, no significant differences were observed in antibiotic resistance rates between the two groups, albeit more diverse genotypes were found in non-PJI-associated MRSA. Our findings therefore suggest that deep infections may allow MRSA to evade antibiotic attack and facilitate the convergent evolution and selection of multidrug-resistant lineages.

[1]  R. Sebra,et al.  Sequential evolution of virulence and resistance during clonal spread of community-acquired methicillin-resistant Staphylococcus aureus , 2019, Proceedings of the National Academy of Sciences.

[2]  Mladen Jecmenica,et al.  Idiosyncratic Drug-Induced Liver Injury Due to Ciprofloxacin: A Report of Two Cases and Review of the Literature , 2018, The American journal of case reports.

[3]  H. Nakaminami,et al.  Change in genotype of methicillin-resistant Staphylococcus aureus (MRSA) affects the antibiogram of hospital-acquired MRSA. , 2018, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

[4]  T. Webster,et al.  Bacteria antibiotic resistance: New challenges and opportunities for implant‐associated orthopedic infections , 2017, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[5]  V. Saini,et al.  Oral-Only Linezolid-Rifampin Is Highly Effective Compared with Other Antibiotics for Periprosthetic Joint Infection , 2017, The Journal of bone and joint surgery. American volume.

[6]  M. Ward,et al.  Identification of source and sink populations for the emergence and global spread of the East-Asia clone of community-associated MRSA , 2016, Genome Biology.

[7]  Yhu-Chering Huang,et al.  A Comparison of Clinical Features between Community-Associated and Healthcare-Associated Methicillin-Resistant Staphylococcus aureus Keratitis , 2015, Journal of ophthalmology.

[8]  Y.-C. Huang,et al.  New epidemiology of Staphylococcus aureus infection in Asia. , 2014, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[9]  Yhu-Chering Huang,et al.  Molecular epidemiology of community-associated meticillin-resistant Staphylococcus aureus in Asia. , 2013, The Lancet. Infectious diseases.

[10]  K. Kaye,et al.  Treatment of Methicillin-Resistant Staphylococcus aureus Infections with a Minimal Inhibitory Concentration of 2 μg/mL to Vancomycin: Old (Trimethoprim/Sulfamethoxazole) versus New (Daptomycin or Linezolid) Agents , 2012, The Annals of pharmacotherapy.

[11]  Benjamin A Lipsky,et al.  Systemic antibiotic therapy for chronic osteomyelitis in adults. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[12]  Yhu-Chering Huang,et al.  Community-associated meticillin-resistant Staphylococcus aureus in children in Taiwan, 2000s. , 2011, International journal of antimicrobial agents.

[13]  D. Nathwani,et al.  MRSA: treating people with infection. , 2010, BMJ clinical evidence.

[14]  R. Gaynes,et al.  Health care-associated and community-associated methicillin-resistant Staphylococcus aureus infections: A comparison of definitions. , 2010, American journal of infection control.

[15]  H. Bukharie A review of community-acquired methicillin-resistant Staphylococcus aureus for primary care physicians , 2010, Journal of family & community medicine.

[16]  F. Lowy Staphylococcus aureus infections. , 2009, The New England journal of medicine.

[17]  R. Daum,et al.  Predominance of Methicillin-Resistant Staphylococcus aureus among Pathogens Causing Skin and Soft Tissue Infections in a Large Urban Jail: Risk Factors and Recurrence Rates , 2008, Journal of Clinical Microbiology.

[18]  B. Diep,et al.  The role of virulence determinants in community-associated MRSA pathogenesis. , 2008, Trends in microbiology.

[19]  S. Crawford,et al.  What is community-associated methicillin-resistant Staphylococcus aureus? , 2008, The Journal of infectious diseases.

[20]  K. Boye,et al.  A new multiplex PCR for easy screening of methicillin-resistant Staphylococcus aureus SCCmec types I-V. , 2007, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[21]  J. Boyce,et al.  Emergence and resurgence of meticillin-resistant Staphylococcus aureus as a public-health threat , 2006, The Lancet.

[22]  N. Flynn,et al.  Comparisons of Community-Associated Methicillin-Resistant Staphylococcus aureus (MRSA) and Hospital-Associated MSRA Infections in Sacramento, California , 2006, Journal of Clinical Microbiology.

[23]  T. Louie,et al.  Novel Multiplex PCR Assay for Detection of the Staphylococcal Virulence Marker Panton-Valentine Leukocidin Genes and Simultaneous Discrimination of Methicillin-Susceptible from -Resistant Staphylococci , 2006, Journal of Clinical Microbiology.

[24]  P. Nordmann,et al.  Three-year survey of community-acquired methicillin-resistant Staphylococcus aureus producing Panton-Valentine leukocidin in a French university hospital. , 2005, The Journal of hospital infection.

[25]  T. Louie,et al.  Novel Multiplex PCR Assay for Characterization and Concomitant Subtyping of Staphylococcal Cassette Chromosome mec Types I to V in Methicillin-Resistant Staphylococcus aureus , 2005, Journal of Clinical Microbiology.

[26]  William R Bishai,et al.  Community-acquired meticillin-resistant Staphylococcus aureus: an emerging threat. , 2005, The Lancet. Infectious diseases.

[27]  Xiao Xue Ma,et al.  Novel Type V Staphylococcal Cassette Chromosome mec Driven by a Novel Cassette Chromosome Recombinase, ccrC , 2004, Antimicrobial Agents and Chemotherapy.

[28]  Susan K. Johnson,et al.  Comparison of community- and health care-associated methicillin-resistant Staphylococcus aureus infection. , 2003, JAMA.

[29]  W. Gransden,et al.  Is methicillin-resistant Staphylococcus aureus more virulent than methicillin-susceptible S. aureus? A comparative cohort study of British patients with nosocomial infection and bacteremia. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[30]  J. Rothgänger,et al.  Typing of Methicillin-Resistant Staphylococcus aureus in a University Hospital Setting by Using Novel Software for spa Repeat Determination and Database Management , 2003, Journal of Clinical Microbiology.

[31]  S. McAllister,et al.  Pulsed-Field Gel Electrophoresis Typing of Oxacillin-Resistant Staphylococcus aureus Isolates from the United States: Establishing a National Database , 2003, Journal of Clinical Microbiology.

[32]  F. Vandenesch,et al.  Community-Acquired Methicillin-Resistant Staphylococcus aureus Carrying Panton-Valentine Leukocidin Genes: Worldwide Emergence , 2003, Emerging infectious diseases.

[33]  Fred C Tenover,et al.  Infection with vancomycin-resistant Staphylococcus aureus containing the vanA resistance gene. , 2003, The New England journal of medicine.

[34]  G. Eliopoulos,et al.  Linezolid resistance in Staphylococcus aureus: characterization and stability of resistant phenotype. , 2002, The Journal of infectious diseases.

[35]  D. Oliveira,et al.  Multiplex PCR Strategy for Rapid Identification of Structural Types and Variants of the mec Element in Methicillin-Resistant Staphylococcus aureus , 2002, Antimicrobial Agents and Chemotherapy.

[36]  Robert S. Daum,et al.  Novel Type of Staphylococcal Cassette Chromosome mec Identified in Community-Acquired Methicillin-Resistant Staphylococcus aureus Strains , 2002, Antimicrobial Agents and Chemotherapy.

[37]  M. Kuroda,et al.  The emergence and evolution of methicillin-resistant Staphylococcus aureus. , 2001, Trends in microbiology.

[38]  H. Chambers,et al.  The changing epidemiology of Staphylococcus aureus? , 2001, Emerging infectious diseases.

[39]  Nicholas P. J. Day,et al.  Multilocus Sequence Typing for Characterization of Methicillin-Resistant and Methicillin-Susceptible Clones ofStaphylococcus aureus , 2000, Journal of Clinical Microbiology.

[40]  M. Jevons “Celbenin” - resistant Staphylococci , 1961 .

[41]  R. Knox “Celbenin”-resistant Staphylococci , 1960 .

[42]  J. A. Andrews,et al.  Linezolid resistance in clinical isolates of Staphylococcus aureus. , 2003, The Journal of antimicrobial chemotherapy.